Document is current
Any future updates will be listed below
-
Authors
Allajbeu, Iris https://orcid.org/0000-0002-6419-2422
Charnley, Kate R.
Yang, Yuyin
Field-Rayner, Johanna
Morris, Kirsten
Payne, Nicholas R.
Kilburn-Toppin, Fleur
Manavaki, Roido
Gilbert, Fiona J.
-
Funding
Funding for this research was provided by:
Cancer Research UK Cambridge Institute, University of Cambridge
GE Healthcare
Bayer, United Kingdom
- License Information
-
More Information
Article History
Received: 28 May 2025
Accepted: 20 November 2025
First Online: 16 January 2026
Declarations
:
: The BRAID (Breast Screening: Risk Adaptive Imaging for Density) trial (NCT04097366) received ethical approval from the National Research Ethics Service (NRES) Committee London – Surrey; REC no: 19/LO/0350. Additional approval for the service evaluation was provided by Cambridge University Hospitals NHS Foundation Trust (2024/BR-117). All participants provided written informed consent prior to taking part.
: Written informed consent, including consent for publication, was obtained from all participants.
: The authors of this manuscript declare relationships with the following companies: GE Healthcare, Bayer Healthcare.
